Table 1.
Baseline characteristic of survivors and non-survivors (30 days).
Fig 1.
Relative miR-122 expression in control patients, sepsis survivors, and sepsis non-survivors.
Means with standard error of the mean.
Table 2.
Correlation between relative miRNA-122 expression (ΔCT) with other laboratory markers and cardiovascular variables.
Fig 2.
Receiver operating characteristics of miR-122 expression, total serum bilirubin concentration, and SOFA-score in relation to 30-day-mortality.
Measurements on day 1 in patients with sepsis.
Fig 3.
Kaplan-Meier estimates according thirty-day survival in patients with sepsis stratified for miR-122 expression.
Table 3.
Cox regression analysis in patients with sepsis stratified for miR-122 expression.
Fig 4.
Receiver operating characteristics of SOFA-score and SOFA-score with added miR-122 expression on day 1 in patients with sepsis in relation to 30-day-mortality.
Measurements on day 1 in patients with sepsis.